Cancer Drug May be Useful with Parkinson’s, Alzheimer’s
March 22, 2017
Nilotinib, a drug approved to treat leukemia, has been green-lit for more tests to prove its efficacy in treating Alzheimer’s and Parkinson’s. More, here.
Hi,
And welcome to my blog. I’m Michael D. Weinraub, a certified elder law attorney*. My practice is holistic; not only do I offer Estate Planning and Administration, Guardianships and Special Needs Trusts, but I also help families plan for, pay for, and coordinate the long-term care of elderly loved ones. Here on my blog I post news tidbits that I find interesting and useful for the ageing and elderly. I hope you find them useful as well.
Best regards,
Mike
Nilotinib, a drug approved to treat leukemia, has been green-lit for more tests to prove its efficacy in treating Alzheimer’s and Parkinson’s. More, here.
CNBC reports on a new study published in the journal Cell Systems, which cites a genetic variant that strongly impacts how the brain ages. More,
Becca R. Levy, a professor of epidemiology at Yale University of Public Health, led a team that used results from the Health and Retirement Study
Jean Chatzky had a piece on Today.com a while back about the benefits of continuing to work. More, here.
A new study, published in the journal Cell Metabolism, cites high-intensity interval training (HIIT) as the best exercise method to reverse signs of aging. More,
Northwestern University published a study recently about the positive effects of sound waves in older adults. More, here.
